ESTEEM Trademark

Trademark Overview

On Monday, August 16, 2010, a trademark application was filed for ESTEEM with the United States Patent and Trademark Office. The USPTO has given the ESTEEM trademark a serial number of 85108116. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, November 26, 2021. This trademark is owned by Celgene Corporation. The ESTEEM trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Conducting clinical trials; conducting clinical trials on the safety and effectiveness of apremilast
esteem

General Information

Serial Number85108116
Word MarkESTEEM
Filing DateMonday, August 16, 2010
Status710 - CANCELLED - SECTION 8
Status DateFriday, November 26, 2021
Registration Number3967975
Registration DateTuesday, May 24, 2011
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 16, 2010

Trademark Statements

Goods and ServicesConducting clinical trials; conducting clinical trials on the safety and effectiveness of apremilast

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, November 26, 2021
Primary Code042
First Use Anywhere DateTuesday, August 31, 2010
First Use In Commerce DateTuesday, August 31, 2010

Trademark Owner History

Party NameCelgene Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Trademark Events

Event DateEvent Description
Friday, November 26, 2021CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Sunday, May 24, 2020COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, August 4, 2016NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, August 4, 2016REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, August 4, 2016CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, May 24, 2016TEAS SECTION 8 & 15 RECEIVED
Tuesday, May 24, 2016COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, July 28, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 24, 2011REGISTERED-PRINCIPAL REGISTER
Friday, April 22, 2011NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, April 21, 2011LAW OFFICE REGISTRATION REVIEW COMPLETED
Monday, April 18, 2011ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, March 24, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 24, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 16, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 24, 2011NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, February 24, 2011NON-FINAL ACTION E-MAILED
Thursday, February 24, 2011SU - NON-FINAL ACTION - WRITTEN
Friday, February 4, 2011STATEMENT OF USE PROCESSING COMPLETE
Tuesday, January 11, 2011USE AMENDMENT FILED
Friday, February 4, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, January 11, 2011TEAS STATEMENT OF USE RECEIVED
Tuesday, January 11, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 16, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 16, 2010PUBLISHED FOR OPPOSITION
Tuesday, October 12, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, October 12, 2010ASSIGNED TO LIE
Monday, September 27, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, September 27, 2010ASSIGNED TO EXAMINER
Thursday, August 19, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, August 19, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

esteem conducting trials clinical apremilast safety effectiveness